Product Details
| Manufacturer | Cipla Ltd |
| Life | 1 Year 11 Month from the Date of Manufacturing |
| Form | Tablets |
| Uses | Heart And Bp |
| Strength | 12.5mg |
| MRP | 1320/Box |
| |
Bosentans mechanism of action involves inhibiting the bodys endogenous chemical endothelin, which constricts blood vessels. Bosentan reduces blood flow resistance by widening blood vessels and inhibiting endothelin receptors, which lowers blood pressure in the pulmonary arteries and relaxes blood vessels.
Bosentan is prescribed to treat pulmonary arterial hypertension (PAH) in both adults and children who are three years old and older. It can be applied to patients with genetic PAH, connective tissue disease-related PAH, and idiopathic PAH (of unknown cause).
Interested in this product?
Ask for more details & Latest Price from seller
Manufacturer of ofloxacin ornidazole tablets, ofloxacin and serratioptidase tablets, herbal syrup, paracetamol tablets, fluocinolone acetonide neomycin cream, softgel capsules, betahistine pills, eye drops, and cetirizine tablets IP
